Palbociclib price after insurance

Palbociclib (Palbociclib) has been approved for the treatment of women with advanced hormone receptor-positive breast cancer. As part of antihormonal therapy, in combination with an aromatase inhibitor or the antiestrogen drug fulvestrant. If possible, breast tumors are surgically removed. But sometimes the tumor has grown too large, or the cancer has spread to other parts of the body through the blood or lymphatic system (metastasize). This is called advanced breast cancer. The growth of tumor cells in breast cancer is affected by many factors. The drug palbociclib has been approved for use in women with advanced breast cancer whose cancer cells carry receptors for hormones such as estrogen or progesterone. This type of tumor is called a hormone receptor-positive (HR-positive) cancer. In these tumors, hormones such as estrogen or progesterone accelerate the growth of cancer cells.

PalbociclibThe original drug has been launched in China and has been included in medical insurance. Currently, reimbursement is limited to patients who meet the indications. The price of common specifications100mg*21 pills per box may be more than 6,000 yuan. The reimbursement ratio is different in different regions. The price after reimbursement may be different. Patients can consult at local hospitals or medical insurance bureaus. The price of original research drugs sold overseas is more expensive, and the price of each box of 125mg*21 tablets may be around 10,000 yuan (the price may fluctuate due to the exchange rate). Palbociclib generics are also sold overseas. The ingredients of the drug are basically the same as those sold domestically and abroad, but the price is cheap. For example, the price of a box of 125mg*21 tablets produced by a Bangladesh pharmaceutical factory may be several hundred yuan (the price may fluctuate due to the exchange rate).